84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]許麗梅,李慧,許云騰,等.基于NF-κB信號(hào)通路探討?yīng)毣罴纳鷾种浦嗵钦T導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制[J].中醫(yī)正骨,2019,31(07):9-14.
　XU Limei,LI Hui,XU Yunteng,et al.An experimental study of mechanism of action of Duhuo Jisheng Tang(獨(dú)活寄生湯)in inhibiting inflammatory reaction induced by lipopolysaccharide in chondrocytes based on NF-κB signaling pathway[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(07):9-14.
點(diǎn)擊復(fù)制

基于NF-κB信號(hào)通路探討?yīng)毣罴纳鷾种浦嗵钦T導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第31卷
期數(shù):
2019年07期
頁(yè)碼:
9-14
欄目:
基礎(chǔ)研究
出版日期:
2019-07-20

文章信息/Info

Title:
An experimental study of mechanism of action of Duhuo Jisheng Tang(獨(dú)活寄生湯)in inhibiting inflammatory reaction induced by lipopolysaccharide in chondrocytes based on NF-κB signaling pathway
作者:
許麗梅1; 李慧2; 許云騰1; 王圣杰2; 曾建偉1; 王麗麗1; 葉蕻芝3; 李西海1
(1.福建中醫(yī)藥大學(xué)中西醫(yī)結(jié)合研究院,福建 福州 350122; 2.福建中醫(yī)藥大學(xué)藥學(xué)院,福建 福州 350122; 3.福建省中西醫(yī)結(jié)合老年性疾病重點(diǎn)實(shí)驗(yàn)室,福建 福州 350122)
Author(s):
XU Limei1; LI Hui2; XU Yunteng1; WANG Shengjie2; ZENG Jianwei1; WANG Lili1; YE Hongzhi3; LI Xihai1
1.Academy of Integrated Medicine affiliated to Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China 2.Pharmaceutical college of Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China 3.Fujian Key Laboratory of Integrated Medicine on Geriatrics,Fuzhou 350122,Fujian,China
關(guān)鍵詞:
骨關(guān)節(jié)炎;  軟骨細(xì)胞;  獨(dú)活寄生湯;  炎癥反應(yīng);  脂多糖類;  NF-κB
Keywords:
osteoarthritis;  chondrocytes;  Duhuo Jisheng Tang;  inflammatory response;  lipopolysaccharides;  NF-kappa B
摘要:
目的:基于NF-κB信號(hào)通路探討?yīng)毣罴纳鷾种浦嗵钦T導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制。方法:取4周齡SPF級(jí)SD大鼠雙側(cè)膝關(guān)節(jié)軟骨,分離軟骨細(xì)胞進(jìn)行體外培養(yǎng)。取培養(yǎng)的第2代軟骨細(xì)胞,隨機(jī)分為5組。空白組中加入含10%FBS的DMEM培養(yǎng)基,模型組加入含10 ng·mL-1脂多糖的10%FBS DMEM培養(yǎng)基,獨(dú)活寄生湯低、中、高濃度組加入含脂多糖(10 ng·mL-1)和獨(dú)活寄生湯(濃度分別為100 μg·mL-1、200 μg·mL-1、300 μg·mL-1)的10%FBS DMEM培養(yǎng)基。干預(yù)8 h后,采用ELISA法測(cè)定各組細(xì)胞培養(yǎng)液上清液中的基質(zhì)金屬蛋白酶(matrix metalloproteinase,MMP)-9含量,確定獨(dú)活寄生湯最佳干預(yù)濃度。隨后取培養(yǎng)的第2代軟骨細(xì)胞,隨機(jī)分為4組。空白組不進(jìn)行干預(yù),模型組加入10 ng·mL-1脂多糖,獨(dú)活寄生湯組加入10 ng·mL-1脂多糖和最佳濃度的獨(dú)活寄生湯,抑制劑組加入10 ng·mL-1脂多糖和10 μmol吡咯烷二硫代甲酸銨鹽。干預(yù)8 h后,采用熒光定量PCR法檢測(cè)軟骨細(xì)胞中NF-κB基因含量、用免疫熒光檢測(cè)法觀察軟骨細(xì)胞中NF-κB蛋白核轉(zhuǎn)位情況。結(jié)果:①獨(dú)活寄生湯最佳干預(yù)濃度測(cè)定結(jié)果。空白組、模型組、獨(dú)活寄生湯低濃度組、獨(dú)活寄生湯中濃度組、獨(dú)活寄生湯高濃度組的MMP-9含量比較,差異有統(tǒng)計(jì)學(xué)意義[(0.125±0.012)ng·mL-1,(0.154±0.008)ng·mL-1,(0.148±0.012)ng·mL-1,(0.148±0.010)ng·mL-1,(0.134±0.002)ng·mL-1,χ2=10.034,P=0.040]。模型組的MMP-9含量高于空白組和獨(dú)活寄生湯高濃度組(P=0.002,P=0.006); 空白組與獨(dú)活寄生湯高濃度組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.573); 獨(dú)活寄生湯低、中濃度組MMP-9含量與模型組比較,差異均無(wú)統(tǒng)計(jì)學(xué)意義(P=0.483,P=0.356)。上述測(cè)定結(jié)果顯示獨(dú)活寄生湯最佳干預(yù)濃度為300 μg·mL-1。②軟骨細(xì)胞中NF-κB基因含量。空白組、模型組、獨(dú)活寄生湯組、抑制劑組的NF-κB基因含量比較,差異有統(tǒng)計(jì)學(xué)意義[1.013±0.015,1.848±0.216,1.454±0.250,1.289±0.332,F=8.859,P=0.002]。模型組的NF-κB基因含量高于空白組、獨(dú)活寄生湯組和抑制劑組(P=0.000,P=0.035,P=0.006); 獨(dú)活寄生湯組的NF-κB基因含量高于空白組(P=0.021); 獨(dú)活寄生湯組的NF-κB基因含量與抑制劑組比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.341)。③軟骨細(xì)胞中NF-κB蛋白核轉(zhuǎn)位情況。各組軟骨細(xì)胞核均呈藍(lán)色; 軟骨細(xì)胞NF-κB蛋白染色明顯,呈綠色; 模型組NF-κB蛋白核轉(zhuǎn)位最為明顯,空白組、抑制劑組NF-κB蛋白核轉(zhuǎn)位相對(duì)較少,獨(dú)活寄生湯組NF-κB蛋白核轉(zhuǎn)位情況介于空白組與模型組之間。結(jié)論:獨(dú)活寄生湯可通過(guò)抑制NF-κB蛋白核轉(zhuǎn)位,減輕脂多糖誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng),從而延緩軟骨退變。
Abstract:
Objective:To explore the mechanism of action of Duhuo Jisheng Tang(獨(dú)活寄生湯,DHJST)in inhibiting inflammatory reaction induced by lipopolysaccharide(LPS)in chondrocytes based on NF-κB signaling pathway.Methods:The 4-week-old SPF-grade SD rats were executed and their articular cartilages were fetched out from both knees,and the chondrocytes were extracted from the knee cartilage tissues and were cultured in vitro.The second-generation chondrocytes were divided into 5 groups,and were cultured in DMEM added with 10% FBS(blank group),10% FBS and LPS(10 ng/mL)(model group),10% FBS,LPS(10 ng/mL)and DHJST(100 μg/mL)(DHJST low-concentration group),10% FBS,LPS(10 ng/mL)and DHJST(200 μg/mL)(DHJST middle-concentration group)and 10% FBS,LPS(10 ng/mL)and DHJST(300 μg/mL)(DHJST high-concentration group)respectively.The content of matrix metalloproteinase(MMP)-9 in supernatant of cell culture fluid of each group were measured by using ELISA method after 8-hour intervention to determine the optimal intervention concentration of DHJST.Then the second-generation chondrocytes were randomly divided into blank group,model group,DHJST group and inhibitor group.The chondrocytes in blank group were not intervened and the chondrocytes in the other three groups were cultured in DMEM added with LPS(10 ng/mL),DMEM added with LPS(10 ng/mL)and DHJST with optimal concentration and DMEM added with LPS(10 ng/mL)and PDTC(10 μmol)respectively.After 8-hour intervention,the gene content of NF-κB in chondrocytes were detected by using fluorescent quantitative PCR method,and nuclear translocation of NF-κB protein in chondrocytes were detected by using immunofluorescence assay.Results:There was statistical difference in content of MMP-9 between blank group,model group,DHJST low-,middle- and high-concentration group(0.125+/-0.012,0.154+/-0.008,0.148+/-0.012,0.148+/-0.010,0.134+/-0.002 ng/mL,χ2=10.034,P=0.040).The content of MMP-9 was higher in model group compared to blank group and DHJST high-concentration group(P=0.002,P=0.006),and there was no statistical difference in content of MMP-9 between blank group and DHJST high-concentration group(P=0.573).There was no statistical difference in content of MMP-9 between DHJST low-concentration group and model group and between DHJST middle-concentration group and model group(P=0.483,P=0.356).Above results showed that the optimal intervention concentration of DHJST was 300 μg/mL.There was statistical difference in gene content of NF-κB between blank group,model group,DHJST group and inhibitor group(1.013+/-0.015,1.848+/-0.216,1.454+/-0.250,1.289+/-0.332,F=8.859,P=0.002).The gene content of NF-κB was higher in model group compared to blank group,DHJST group and inhibitor group,and was higher in DHJST group compared to blank group(P=0.000,P=0.035,P=0.006; P=0.021).There was no statistical difference in gene content of NF-κB between DHJST group and inhibitor group(P=0.341).The cytoblast of chondrocytes presented with blue staining in each group.The chondrocytes presented with obvious green staining of NF-κB protein.The most obvious nuclear translocations of NF-κB protein were found in model group,and relatively less nuclear translocations of NF-κB protein were found in blank group and inhibitor group,and the nuclear translocation of NF-κB protein in DHJST group was between blank group and model group.Conclusion:DHJST can alleviate inflammatory reaction induced by LPS in chondrocytes through inhibiting nuclear translocation of NF-κB protein,which may be the mechanisms of action for delaying articular cartilage degeneration.

參考文獻(xiàn)/References:


[1] CORR E M,CUNNINGHAM C C,HELBERT L,et al.Osteoarthritis-associated basic Calcium phosphate crystals activate membrane proximal kinases in human innate immune cells[J].Arthritis Res Ther,2017,19(1):23.
[2] SCANZELLO C R.Role of low-grade inflammation in osteoarthritis[J].Curr Opin Rheumatol,2017,29(1):79-85.
[3] SHEN J,ABU-AMER Y,O'KEEFE R J,et al.Inflammation and epigenetic regulation in osteoarthritis[J].Connect Tissue Res,2017,58(1):49-63.
[4] 周江濤,趙依娜,王慶來(lái).獨(dú)活寄生湯口服聯(lián)合玻璃酸鈉關(guān)節(jié)腔注射治療早中期膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2019,31(2):17-21.
[5] 何曉娟,林平冬,馬玉環(huán),等.獨(dú)活寄生湯含藥血清抑制白細(xì)胞介素1β誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(8):1-7.
[6] 鄭文偉,翁霞萍,黃綏心,等.獨(dú)活寄生湯對(duì)骨關(guān)節(jié)炎軟骨退變的影響及其作用機(jī)制[J].中醫(yī)正骨,2017,29(7):5-11.
[7] OLIVOTTO E,OTERO M,MARCU K B,et al.Pathophysiology of osteoarthritis:canonical NF-kappaB/IKKbeta-dependent and kinase-independent effects of IKKalpha in cartilage degradation and chondrocyte differentiation[J].RMD Open,2015,1(Suppl 1):e 000061.
[8] ZHONG J H,LI J,LIU C F,et al.Effects of microRNA-146a on the proliferation and apoptosis of human osteoarthritis chondrocytes by targeting TRAF6 through the NF-kappa B signalling pathway[J].Biosci Rep,2017,37(2)[2019-04-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408711.
[9] 陳后煌,邵翔,葉蕻芝,等.獨(dú)活寄生湯對(duì)脂多糖誘導(dǎo)的大鼠軟骨細(xì)胞炎癥模型IL-1β、TNF-α表達(dá)的影響[J].中華老年骨科與康復(fù)電子雜志,2017,3(2):77-84.
[10] 李西海,劉獻(xiàn)祥.骨關(guān)節(jié)炎的核心病機(jī)——本痿標(biāo)痹[J].中醫(yī)雜志,2014,55(14):1248-1249.
[11] 李西海,梁文娜,葉蕻芝,等.獨(dú)活寄生湯調(diào)控風(fēng)寒濕痹型骨關(guān)節(jié)炎軟骨下骨重建失衡的作用機(jī)制探討[J].風(fēng)濕病與關(guān)節(jié)炎,2014,3(8):62-64.
[12] HWANG H S,KIM H A.Chondrocyte apoptosis in the pathogenesis of osteoarthritis[J].Int J Mol Sci,2015,16(11):26035-26054.
[13] RAHMATI M,NALESSO G,MOBASHERI A,et al.Aging and osteoarthritis:Central role of the extracellular matrix[J].Ageing Res Rev,2017,40:20-30.
[14] CUI N,HU M,KHALIL R A.Biochemical and biological attributes of matrix metalloproteinases[J].Prog Mol Biol Transl Sci,2017,147:1-73.
[15] ZENG G Q,CHEN A B,LI W,et al.High MMP-1,MMP-2,and MMP-9 protein levels in osteoarthritis[J].Genet Mol Res,2015,14(4):14811-14822.
[16] SESTITO S E,FACCHINI F A,MORBIOLI I A,et al.Amphiphilic guanidinocalixarenes inhibit lipopolysaccharide(LPS)- and Lectin-Stimulated toll-like receptor 4(TLR4)signaling[J].J Med Chem,2017,60(12):4882-4892.
[17] LU Y C,YEH W C,OHASHI P S.LPS/TLR4 signal transduction pathway[J].Cytokine,2008,42(2):145-151.
[18] ROY A,SRIVASTAVA M,SAQIB U,et al.Potential therapeutic targets for inflammation in toll-like receptor 4(TLR4)-mediated signaling pathways[J].Int Immunopharmacol,2016,40:79-89.
[19] LEPETSOS P,PAPAVASSILIOU K A,PAPAVASSILIOU A G.Redox and NF-kappa B signaling in osteoarthritis[J].Free Radic Biol Med,2019,132:90-100.
[20] SAITO T,TANAKA S.Molecular mechanisms underlying osteoarthritis development:Notch and NF-kB[J].Arthritis Res Ther,2017,19(1):94.
[21] MITCHELL J P, CARMODY R J.NF-κB and the transcriptional control of inflammation[J].Int Rev Cell Mol Biol,2018,335:41-84.
[22] LIN T H,PAJARINEN J,LU L,et al.NF-κB as a therapeutic target in inflammatory-associated bone diseases[J].Adv Protein Chem Struct Biol,2017,107:117-154.
[23] HAYDEN M S,GHOSH S.Regulation of NF-kappa B by TNF family cytokines[J].Semin Immunol,2014,26(3):253-266.

相似文獻(xiàn)/References:

[1]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[2]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[3]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進(jìn)展[J].中醫(yī)正骨,2015,27(10):68.
[4]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評(píng)價(jià)[J].中醫(yī)正骨,2015,27(09):9.
　LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):9.
[5]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[6]劉紅娟,郭會(huì)利,郭樹農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護(hù)理[J].中醫(yī)正骨,2015,27(08):75.
[7]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式 和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[8]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補(bǔ)腎柔肝藥和活血祛風(fēng)藥治療 骨關(guān)節(jié)炎作用方式的計(jì)算機(jī)模擬比較[J].中醫(yī)正骨,2015,27(07):6.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補(bǔ)腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):6.
[9]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機(jī)制研究[J].中醫(yī)正骨,2015,27(07):15.
　SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):15.
[10]梅其杰,袁長(zhǎng)深,段戡,等.壯藥骨痹方燙熨聯(lián)合運(yùn)動(dòng)療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
　MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):27.
[11]鄭春松,葉蕻芝,李西海,等.獨(dú)活寄生湯含藥血清對(duì)白細(xì)胞介素1β誘導(dǎo)的 退變關(guān)節(jié)軟骨細(xì)胞中基質(zhì)金屬蛋白酶 和環(huán)氧化酶2表達(dá)的影響[J].中醫(yī)正骨,2015,27(12):1.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(獨(dú)活寄生湯)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):1.
[12]林木南,林艷紅,劉獻(xiàn)祥,等.溫?zé)崾杳懿▽?duì)膝骨關(guān)節(jié)炎模型大鼠軟骨細(xì)胞 RAS/絲裂原活化蛋白激酶信號(hào)通路的影響[J].中醫(yī)正骨,2016,28(02):1.
　LIN Munan,LIN Yanhong,LIU Xianxiang,et al.Effect of warm sparse-dense wave on RAS/mitogen-activated protein kinase signaling pathway in chondrocytes of knee osteoarthritis rat models[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):1.
[13]原曉強(qiáng),金王東,周云婧,等.純化血小板對(duì)大鼠軟骨細(xì)胞增殖及膝骨關(guān)節(jié)炎大鼠軟骨修復(fù)的作用研究[J].中醫(yī)正骨,2016,28(12):6.
　YUAN Xiaoqiang,JIN Wangdong,ZHOU Yunjing,et al.Effect of purified platelet rich plasma on chondrocyte proliferation in rats and cartilage repair in rats with knee osteoarthritis:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):6.
[14]劉啟明,羅統(tǒng)富,董黎強(qiáng),等.植物雌激素類中藥延緩關(guān)節(jié)軟骨細(xì)胞退變的研究進(jìn)展[J].中醫(yī)正骨,2017,29(05):27.
[15]葉錦霞,付長(zhǎng)龍,林潔,等.透骨消痛膠囊對(duì)毒胡蘿卜素誘導(dǎo)的內(nèi)質(zhì)網(wǎng)應(yīng)激PEKR信號(hào)通路介導(dǎo)的大鼠體外培養(yǎng)關(guān)節(jié)軟骨細(xì)胞凋亡的影響[J].中醫(yī)正骨,2017,29(06):1.
　YE Jinxia,FU Changlong,LIN Jie,et al.Effect of Tougu Xiaotong Jiaonang(透骨消痛膠囊)on apoptosis mediated by endoplasmic reticulum stress(PEKR signaling pathway)and induced by thapsigargin in rat's articular chondrocytes cultured in vitro[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(07):1.
[16]何曉娟,林平冬,馬玉環(huán),等.獨(dú)活寄生湯含藥血清抑制白細(xì)胞介素1β誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(08):1.
　HE Xiaojuan,LIN Pingdong,MA Yuhuan,et al.Study on mechanism of action of Duhuo Jisheng Tang(獨(dú)活寄生湯)medicated serum in inhibiting inflammatory reaction induced by interleukin-1 beta in chondrocytes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(07):1.
[17]鄭文偉,何曉娟,賈良良,等.跳骨片含藥血清抑制脂多糖誘導(dǎo)的軟骨細(xì)胞炎癥反應(yīng)的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(08):8.
　ZHENG Wenwei,HE Xiaojuan,JIA Liangliang,et al.Study on mechanism of action of Tiaogu Pian(跳骨片)medicated serum in inhibiting inflammatory reaction induced by lipopolysaccharides in chondrocytes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(07):8.
[18]陳世宣,劉益杰,胡笑燊,等.基于瞬時(shí)受體電位香草素亞家族4信號(hào)通路探討牛蒡子苷元對(duì)體外培養(yǎng)軟骨細(xì)胞增殖及Ⅱ型膠原蛋白和軟骨蛋白聚糖表達(dá)的影響[J].中醫(yī)正骨,2017,29(10):13.
　CHEN Shixuan,LIU Yijie,HU Xiaoshen,et al.An experimental study of effect of arctigenin on proliferation of chondrocyte cultured in vitro and expression of typeⅡcollagen protein and aggrecan based on the transient receptor potential vanilloid 4 signaling pathway[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(07):13.
[19]陳俊,吳廣文,許惠鳳,等.獨(dú)活寄生湯含藥血清對(duì)大鼠退變軟骨細(xì)胞蛋白激酶 R樣內(nèi)質(zhì)網(wǎng)激酶/免疫球蛋白結(jié)合蛋白信號(hào)通路的影響[J].中醫(yī)正骨,2018,30(08):1.
　CHEN Jun,WU Guangwen,XU Huifeng,et al.Effect of Duhuo Jisheng Tang(獨(dú)活寄生湯)medicated serum on protein kinase R-like endoplasmic reticulum kinase/immunoglobulin-binding protein signaling pathway in degenerated chondrocytes of rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(07):1.
[20]王會(huì)含,王永堂,苗建華,等.川芎嗪對(duì)人骨關(guān)節(jié)炎軟骨細(xì)胞的影響及作用機(jī)制研究[J].中醫(yī)正骨,2021,33(07):4.
　WANG Huihan,WANG Yongtang,MIAO Jianhua,et al.A study of the effects of tetramethylpyrazine on human osteoarthritic chondrocytes and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(07):4.

備注/Memo

備注/Memo:
基金項(xiàng)目:國(guó)家自然科學(xué)基金項(xiàng)目(81573998); 中國(guó)博士后科學(xué)基金第60批面上資助項(xiàng)目(2016M600625); 中國(guó)博士后科學(xué)基金第10批特別資助項(xiàng)目(2017T100591) 通訊作者:李西海 E-mail:[email protected](收稿日期:2019-06-05 本文編輯:李曉樂)
更新日期/Last Update: 2019-07-20